The Clinical Global Impressions scale: errors in understanding and use.

[1]  J. Lieberman,et al.  Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)) , 2009 .

[2]  Russell L. Kolts,et al.  Relationship Between Depression Severity Entry Criteria and Antidepressant Clinical Trial Outcomes , 2007, Biological Psychiatry.

[3]  G. Kinrys,et al.  Adjunctive zonisamide for treatment refractory anxiety , 2007, International journal of clinical practice.

[4]  Bruno Falissard,et al.  The improved Clinical Global Impression Scale (iCGI): development and validation in depression , 2007, BMC psychiatry.

[5]  Russell L. Kolts,et al.  Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. , 2004, The American journal of psychiatry.

[6]  J. Lieberman,et al.  First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol , 2004, Schizophrenia Research.

[7]  L. Hothorn,et al.  Impact of the ICH E9 Guideline Statistical Principles for Clinical Trials on the Conduct of Clinical Trials in Japan , 2003 .

[8]  J. Lieberman,et al.  Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. , 2003, The American journal of psychiatry.

[9]  Peter B. Jones,et al.  The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia , 2003, Acta psychiatrica Scandinavica. Supplementum.

[10]  David A. Schoenfeld,et al.  The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach , 2003, Psychotherapy and Psychosomatics.

[11]  Mark E. Schmidt,et al.  Treatment Approaches to Major Depressive Disorder Relapse , 2002, Psychotherapy and Psychosomatics.

[12]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[13]  Robert M. Post,et al.  Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP , 1997, Psychiatry Research.

[14]  M. Beneke,et al.  "Clinical Global Impressions"(ECDEU): Some Critical Comments , 1992, Pharmacopsychiatry.

[15]  M. Detke,et al.  Simple options for improving signal detection in antidepressant clinical trials. , 2007, Psychopharmacology bulletin.